Clinical Journal of Gastroenterology

, Volume 11, Issue 3, pp 229–234 | Cite as

A case of nodal malignant lymphoma presenting with arterial bleeding related to its duodenal penetration

  • Takakazu Miyake
  • Tomoya Iida
  • Yoshiharu Masaki
  • Kei Onodera
  • Toshiyuki Kubo
  • Kentaro Yamashita
  • Hiroo Yamano
  • Hiroshi Nakase
Case Report


A 62-year-old man with a chief complaint of dysphagia visited our hospital. Enhanced computed tomography showed the tumor near the duodenal wall and lymphadenopathy in the left supraclavicular fossa and para-aortic lymph node. Upper gastrointestinal endoscopy showed an ulcer accompanied with a fistula in the anterior wall of duodenal bulb, suggesting that the tumor penetrated into duodenal wall. Biopsy from the lymph node in the left supraclavicular fossa indicated diffuse large B-cell lymphoma. Although chemotherapy was planned, massive arterial bleeding occurred from the part of duodenal penetration. Endoscopic hemostasis was unsuccessfully performed. Therefore, we performed transcathether arterial embolization for hemostasis. After the procedure, the patient received six cycles of chemotherapy, and he achieved complete response. He has been alive 5 years without recurrence. There were many cases of gastrointestinal bleeding from primary gastrointestinal lymphomas, while there were few cases with nodal involvement by malignant lymphoma resulting in bleeding from gastrointestinal tract. We herein report a case of duodenal bleeding by nodal involvement of diffuse large B-cell lymphoma with review of literature.


Malignant lymphoma Diffuse large B-cell lymphoma (DLBCL) Vascular invasion Bleeding Endoscopy 


Compliance with ethical standards

Conflict of interest

No conflict of interest exists for any authors listed in this manuscript.

Human/animal rights

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from the patient for being included in the study.


  1. 1.
    Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood. 2006;107:265–76.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Nakamura S, Matsumoto T. Gastrointestinal lymphoma: recent advances in diagnosis and treatment. Digestion. 2013;87:182–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;2:252–60.CrossRefGoogle Scholar
  4. 4.
    dʼAmore F, Brincker H, Grønbaek K, et al. Non-Hodgkinʼs lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol. 1994;12:1673–84.CrossRefPubMedGoogle Scholar
  5. 5.
    Nakamura S, Matsumoto T, Iida M, et al. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97:2462–73.CrossRefPubMedGoogle Scholar
  6. 6.
    Tomita N. Clinical manifestation and treatment of extranodal diffuse large B-cell lymphoma. Rinsho Ketsueki. 2016;57:1991–9.PubMedGoogle Scholar
  7. 7.
    Valentini M, Bortoluzzi F, Cannizzaro R, et al. Gastroduodenal involvement in staging of nodal non-Hodgkin lymphomas: a clinical and endoscopic prospective study of 235 patients. Am J Gastroenterol. 1995;90:195–6.Google Scholar
  8. 8.
    Ge Z, Liu Z, Hu X. Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma. World J Surg Oncol. 2016;14:85.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Mehta RS, Modi N, Sapanara N, et al. Extranodal marginal zone B-cell mucosa-associated lymphoid tissue (MALT) lymphoma of cecum presenting as bright red bleed per rectum—a case report with review of literature. J Gastrointest Cancer. 2008;39:66–72.CrossRefPubMedGoogle Scholar
  10. 10.
    Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin’s disease staging classification. Cancer Res. 1971;31:1860–1.PubMedGoogle Scholar
  11. 11.
    Talaulikar D, Shadbolt B, Dahlstrom JE, et al. Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI). J Hematol Oncol. 2009;2:49.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. 1978;42:693–707.CrossRefPubMedGoogle Scholar
  13. 13.
    Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.Google Scholar
  14. 14.
    Suzumiya J, Nagano M, Higashihara H, et al. Hemorrhage from abdominal non-Hodgkin’s lymphoma treated successfully by emergency transcatheter arterial embolization. Am J Haematol. 1996;52:201–4.CrossRefGoogle Scholar
  15. 15.
    Unlü Y, Tekin SB, Ceviz M, et al. A successful right axillary artery graft to repair a ruptured axillary artery due to the involvement of lymphoma: report of a case. Surg Today. 2003;33:72–4.CrossRefPubMedGoogle Scholar
  16. 16.
    Li JZ, Tao J, Ruan DY, et al. Primary duodenal NK/T-cell lymphoma with massive bleeding: a case report. World J Clin Oncol. 2012;10:92–7.CrossRefGoogle Scholar
  17. 17.
    Nomura K, Yamada S, Shimizu D, et al. Successful endoscopic hemostasis for gastric arterial bleeding due to invasion of malignant lymphoma. World J Gastroenterol. 2005;21:4285–6.CrossRefGoogle Scholar
  18. 18.
    Balderas V, Spechler SJ. Upper gastrointestinal bleeding in a patient with AIDS. Nat Clin Pract Gastroenterol Hepatol. 2006;3:349–53.CrossRefPubMedGoogle Scholar
  19. 19.
    Cortes M, Fernandes S, Teixeira V, Freitas LC. Upper gastrointestinal bleeding in a patient with Sjögren syndrome. Rev Esp Enferm Dig. 2016;108:576.PubMedGoogle Scholar
  20. 20.
    Sehn LH, Berry B, Chhanabhai M, et al. The Revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2007;109:1857–61.CrossRefPubMedGoogle Scholar
  21. 21.
    Hall PA, Richards MA, Gregory WM, et al. The prognostic value of Ki67 immunostaining in non-Hodgkin’s lymphoma. J Pathol. 1988;154:223–35.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Gastroenterology 2018

Authors and Affiliations

  1. 1.Department of Gastroenterology and HepatologySapporo Medical University School of MedicineSapporoJapan

Personalised recommendations